1. Academic Validation
  2. Negative regulation of toll-like receptor-mediated signaling by Tollip

Negative regulation of toll-like receptor-mediated signaling by Tollip

  • J Biol Chem. 2002 Mar 1;277(9):7059-65. doi: 10.1074/jbc.M109537200.
Guolong Zhang 1 Sankar Ghosh
Affiliations

Affiliation

  • 1 Section of Immunobiology, Department of Molecular Biophysics and Biochemistry, Howard Hughes Medical Institute, Yale University School of Medicine, 310 Cedar Street, New Haven, CT 06520, USA.
Abstract

Toll-like Receptor (TLR)-mediated recognition of pathogens represents one of the most important mechanisms of innate immunity and disease resistance. The adaptor protein Tollip was identified initially as an intermediate in interleukin (IL)-1 signaling. Here we report that Tollip also associates directly with TLR2 and TLR4 and plays an inhibitory role in TLR-mediated cell activation. Inhibition by Tollip is mediated through its ability to potently suppress the activity of IL-1 receptor-associated kinase (IRAK) after TLR activation. In addition, we show for the first time that Tollip is a bona fide substrate for IRAK and is phosphorylated by IRAK upon stimulation with lipopolysaccharide or IL-1. Negative regulation of TLR signaling by Tollip may therefore serve to limit the production of proinflammatory mediators during inflammation and Infection.

Figures